Yes, NP thanked the 'patients who have agreed to participate in our trials' in the NASH IND PR on 4 September and both the mCRC IND and mCRC Phase 2 approval PRs on 8 August and 9 September respectively. He has publicly stated they we will not be advancing these trials at this time, but this very well could be the 'very deep talks' with Bayer, Regeneron or someone else will move these forward soon? I am hoping that they have injected other patients under emergency protocol for TNBC, CRC or another cancer without treatment options and once the whispers get out that leronlimab is extremely safe and effective, patients will be lining up for all these Phase 2 trials.
Either way, there is a lot of very exciting times ahead for CYDY (IMO)) and hoping this party starts tomorrow. BOL
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.